The 12th Invest in ME Research Conference June, 2017, Part 2
MEMum presents the second article in a series of three about the recent 12th Invest In ME International Conference (IIMEC12) in London.
Discuss the article on the Forums.

Rituximab for Hep C not responding to antivirals - relapse risk remains

Discussion in 'Other Health News and Research' started by natasa778, Jan 31, 2014.

  1. natasa778

    natasa778 Senior Member

    Messages:
    1,773
    Likes:
    2,456
    Small scale trial but very encouraging and interesting results

    A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.


     
    Bob likes this.
  2. natasa778

    natasa778 Senior Member

    Messages:
    1,773
    Likes:
    2,456
    Should have mentioned FATIGUE being present in 2/3 of Hep C patients, amongst other clinical presentations. Would be interesting to know if that changes after Rituximab treatment ...

    Cryoglobulin production present in over a third.
     

See more popular forum discussions.

Share This Page